Evidence map›Paper›PMID 35577918›Full record

ArticleNature chemistry2022

E- and Z-trisubstituted macrocyclic alkenes for natural product synthesis and skeletal editing.

Yucheng Mu, Felix W W Hartrampf, Elsie C Yu, Katherine E Lounsbury, Richard R Schrock, Filippo Romiti, Amir H Hoveyda

Open access · greenAbstract read
In one paragraph

Article in Nature chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Catalytic Cross-Metathesis Reactions That AffordJournal of the American Chemical Society · 2023
    Article
  11. Journal of the American Chemical Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Yucheng MuMerkert Chemistry Center, Boston College, Chestnut Hill, MA, USA.ORCID http://orcid.org/0000-0003-1493-2880
Felix W W HartrampfMerkert Chemistry Center, Boston College, Chestnut Hill, MA, USA.
Elsie C YuMerkert Chemistry Center, Boston College, Chestnut Hill, MA, USA.ORCID http://orcid.org/0000-0002-2592-8257
Katherine E LounsburySupramolecular Science and Engineering Institute, University of Strasbourg and CNRS, Strasbourg, France.
Richard R SchrockDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.
Filippo RomitiMerkert Chemistry Center, Boston College, Chestnut Hill, MA, USA. romiti@unistra.fr.ORCID http://orcid.org/0000-0003-1903-9901
Amir H HoveydaMerkert Chemistry Center, Boston College, Chestnut Hill, MA, USA. amir.hoveyda@bc.edu.ORCID http://orcid.org/0000-0002-1470-6456
Boston College · USCentre National de la Recherche Scientifique · FRMassachusetts Institute of Technology · US

Funding

New Catalysts, Strategies and Methods for Stereoselective Chemical SynthesisR35GM130395 · NIGMS · BOSTON COLLEGE · PI AMIR H HOVEYDA · 2019 to 2026
$4.4M
NIGMS NIH HHS R35 GM130395
6 · The paper itself

Abstract

Many therapeutic agents are macrocyclic trisubstituted alkenes but preparation of these structures is typically inefficient and non-selective. A possible solution would entail catalytic macrocyclic ring-closing metathesis, but these transformations require high catalyst loading, conformationally rigid precursors and are often low yielding and/or non-stereoselective. Here we introduce a ring-closing metathesis strategy for synthesis of trisubstituted macrocyclic olefins in either stereoisomeric form, regardless of the level of entropic assistance. The goal was achieved by addressing several unexpected difficulties, including complications arising from pre-ring-closing metathesis alkene isomerization. The power of the method is highlighted by two examples. The first is the near-complete reversal of substrate-controlled selectivity in the formation of a macrolactam related to an antifungal natural product. The other is a late-stage stereoselective generation of an E-trisubstituted alkene in a 24-membered ring, en route to the cytotoxic natural product dolabelide C.

Indexed as

AlkenesBiological ProductsCatalysisCyclizationStereoisomerismAlkenesBiological Products

Identifiers

PMID35577918
PMCPMC9191848
OpenAlexW4280610739

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.